Table 4.

The amounts of major free fatty acids (FFAs) as % of total amount in plasma of patients with metabolic syndrome, RA, and cancer. Results were expressed as means ± SEM (compared to control, *P < .001, **P < .05).

FFAs	Control (n = 23)	Metabolic syndrome (n = 26)	Cancer (n = 13)	RA (n = 15)
14 : 0	1.99 ± 0.27	2.02 ± 0.14	1.41 ± 0.29	1.82 ± 0.20
16 : 0	26.96 ± 0.64	26.95 ± 0.56	25.73 ± 0.75	29.14 ± 0.83**
16 : 1 (n − 7)	4.20 ± 0.51	5.21 ± 0.28	4.48 ± 0.56	4.06 ± 0.43
18 : 0	7.09 ± 0.35	5.76 ± 0.42**	4.62 ± 0.18*	8.04 ± 0.50
18 : 1 (n − 9)	19.43 ± 0.48	19.56 ± 0.60	19.25 ± 0.81	21.57 ± 1.00**
18 : 2 (n − 6)	35.06 ± 1.44	32.72 ± 0.83	36.54 ± 1.93	30.73 ± 1.64
20 : 4 (n − 6)	4.72 ± 0.42	5.97 ± 0.41**	7.58 ± 0.62*	4.40 ± 0.57
20 : 3 (n − 6)	2.19 ± 0.21	1.95 ± 0.01	1.76 ± 0.28	2.53 ± 0.42